Onglyza MDL Awaiting Approval Status
Onglyza MDL Awaiting Approval Status
Introduction
Another heart failure lawsuit filed recently now awaits a nod for from the U.S. Judicial Panel on Multidistrict Litigation for centralization of all federally-filed Onglyza and Kombiglyze XR lawsuits in a single U.S. District Court for coordinated pretrial proceedings. The number of lawsuits filed has already crossed 40 and is expected to eventually grow to include hundreds of similar cases.
The JPML was scheduled to hear oral arguments on January 25, 2018, to decide whether consolidation was necessary or not. The court records show more than 42 product liability lawsuits pending in the federal court system filed by individuals who developed congestive heart failure and other side effects of diabetes drug.
Comments
Latest News
Court Approves $700M Opioid Settlement for Acute Hospitals
Categories: Opioids
A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.
The settlement consolidates four separate agreements involving major drug…
Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B
Categories: Philips CPAP/BiPAP/ASV Sleep Apnea Machines
Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.
The breakdown of the foam in these machines may release harmful chemicals, raising serious…
Texas Trial to Decide J&J’s $10B Talcum Powder Settlement
Categories: Talcum
A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…